Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19267351

Prostate 2009 Jun 15 69 9 938-48

Download in:

View as

General Info

PMID
19267351